LÖRRACH, Germany and SAINT LOUIS, France, March 26, 2018 /PRNewswire/ — Allecra Therapeutics, a biopharmaceutical company dedicated to the development of novel antibiotics for the treatment of drug resistant bacterial infections, today announced positive top-line results from the Phase 2…
